14615-28-2

Basic information

• Product Name: 2-AMINO-1-(3-BROMOPHENYL)ETHANOL HYDROCHLORIDE
• Synonyms: 2-AMINO-1-(3-BROMOPHENYL)ETHANOL HYDROCHLORIDE;Benzyl alcohol, -(aminomethyl)-m-bromo-, hydrochloride (8CI);2-aMino-1-(3-broMophenyl)ethan-1-ol hydrochloride;alpha-(Aminomethyl)-3-bromo-benzenemethanol hydrochloride;BenzeneMethanol, a-(aMinoMethyl)-3-broMo-,hydrochloride (1:1);2-Amino-1-(3-Bromophenyl)Ethanol Hydrochloride(WX600167)
• CAS NO: 14615-28-2
• Molecular Formula: C8H11BrClNO
• Molecular Weight: 252.54
• Mol File: 14615-28-2.mol

Chemical Properties

• Melting Point: 245℃ (dec.)
• Appearance: /
• CAS DataBase Reference: 2-AMINO-1-(3-BROMOPHENYL)ETHANOL HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMINO-1-(3-BROMOPHENYL)ETHANOL HYDROCHLORIDE(14615-28-2)
• EPA Substance Registry System: 2-AMINO-1-(3-BROMOPHENYL)ETHANOL HYDROCHLORIDE(14615-28-2)

Safety Data

• Hazardous Substances Data: 14615-28-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Development:
2-AMINO-1-(3-BROMOPHENYL)ETHANOL HYDROCHLORIDE is used as a research compound for its potential application in the treatment of various medical conditions. Its unique structure and properties allow it to be explored for possible therapeutic effects and drug development.
Used in Laboratory Settings:
In laboratories, 2-AMINO-1-(3-BROMOPHENYL)ETHANOL HYDROCHLORIDE is used as an experimental chemical due to its distinctive chemical properties. It aids researchers in understanding its potential interactions and effects within different chemical and biological systems.
It is crucial to handle 2-AMINO-1-(3-BROMOPHENYL)ETHANOL HYDROCHLORIDE with care and follow safety guidelines to mitigate any potential hazards associated with its use.

Relevant articles and documents

THIAZOLYL COMPOUNDS USEFUL AS KINASE INHIBITORS

The invention provides compounds of formula I [INSERT CHEMICAL STRUCTURE HERE] (I) and pharmaceutically acceptable salts thereof. The formula I thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.

Imidazole based kinase inhibitors

The present invention provides compounds having Formula I and their use for the treatment of cancer.

Benzimidazole C-2 heterocycles as kinase inhibitors

Benzimidazole derivatives having the general formula I are provided. These compounds are useful as tyrosine kinase inhibitors, especially for the treatment of cancer.

NOVEL TYROSINE KINASE INHIBITORS

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula (I) compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents.

Novel tyrosine kinase inhibitors

The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases which can be treated by inhibiting tyrosine kinase enzymes.